Compare Avalon Labs (AVL) vs Immunefi (IMU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avalon Labs vs Immunefi — how do they compare? Avalon Labs trades at Rp283.99 (market cap Rp45,72M, Rp17,24M 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Avalon Labs is the larger of the two by market cap, and Avalon Labs's circulating supply is 161,7M / 1B AVL (17%) versus 873,4M / 10B IMU (9%) for Immunefi. Which is the better fit depends on your goals — on Pluang, investors hold Avalon Labs for 9 Days and Immunefi for 5 Days on average.
| AVL | IMU | |
|---|---|---|
Market Cap | Rp45,72M | Rp27,03M |
Volume (24h) | Rp17,24M | Rp39,91M |
Circulating Supply | 161,7M / 1B AVL (17%) | 873,4M / 10B IMU (9%) |
Typical Hold Time | 9 Days | 5 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AVL is trading at Rp286.54 with a bearish technical outlook, showing sell signals across moving averages while oscillators remain neutral. The token faces resistance at Rp288 with support at Rp280, indicating potential downside pressure. With only 17% of max supply circulating and average hold time of 9 days, liquidity remains limited. Recent news shows no direct crypto ecosystem developments for this token.
Overall outlook remains cautious with bearish technical momentum outweighing neutral oscillators. Key opportunity lies in potential breakout above Rp288 resistance, while major risks include low liquidity, limited circulation, and absence of recent protocol updates. Investors should monitor for any blockchain ecosystem developments that could drive adoption.
IMU token shows limited market activity with a modest market cap of Rp27.03M and only 9% circulating supply. The token exhibits low trading volume and minimal network activity, with a short average hold time of 5 days indicating speculative trading patterns. Recent coverage appears to confuse this cryptocurrency with a corporate entity, creating market confusion.
Outlook remains cautious due to extremely low liquidity and market confusion with traditional equity. Key risk is entity misidentification impacting proper valuation. Opportunity exists if protocol utility develops, but current fundamentals are weak with minimal ecosystem activity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Avalon Labs
Avalon Labs is building an on-chain financial center for Bitcoin, offering solutions like BTC-backed lending, a Bitcoin-backed stablecoin, yield-generating accounts, and a credit card. Our goal is to create a scalable, transparent, and accessible financial network for Bitcoin holders to use Bitcoin as an economic asset. AVL is the governance token of the Avalon Labs ecosystem. We started as the world's largest issuer of Bitcoin-backed collateralized debt positions (CDPs) and have since expanded into DeFi lending, fixed-rate CeDeFi models, and stablecoins. This growth, driven by community demand, positions Avalon as a leader in on-chain finance. With AVL, we empower our community to actively shape the future of Avalon.
Read more on AVL →About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →
